[1]
“OPTIMAL PHARMACOTHERAPY STRATEGIES IN HYPERTENSION MANAGEMENT: COST ANALYSIS AND DRUG CLASS STRUCTURE”, YHCĐ, vol. 67, no. 3, Mar. 2026, doi: 10.52163/yhc.v67i3.4658.